09:00 - 10:00
Registration
10:00 - 10:05
Opening
Alvydas Česas, Assoc. prof. Sigita Liutkauskienė
10:05 - 12:15
I SESSION
Moderators: Alvydas Česas, Assoc. prof. Sigita Liutkauskienė
10:05 - 10:25
New Neoplastic Breast Cancer Subtypes: Low and Ultra-Low HER2
Gediminas Smailys, Klaipeda University Hospital
10:25 - 10:45
Clinical Utility of liquid biopsy for screening and MRD detection
Dr. Jūratė Gruodė, Klaipeda University Hospital
10:45 - 11:05
Adjuvant therapy after pCR; adjuvant therapy with residual cancer
Assoc. prof. Birutė Brasiūnienė, National Cancer Center, Vilnius University Hospital Santaros Klinikos
11:05 - 11:35
Overview of Latest treatment guidelines on Metastatic Breast Cancer
Prof. Alessandra Gennari, Professor of Oncology at the University of Eastern Piedmont (UPO) and Head of the Division of Oncology at Maggiore University Hospital, Novara, IT (Lecture supported by AstraZeneca)
11:45 - 12:05
5 years of CDK4/6 inhibitors in Lithuania: what have we learned from the treatment of HR+HER2-metastatic breast cancer?
Alvydas Česas, Klaipeda University Hospital
12:05 - 12:25
Implementation AI-based decision support into the clinics: Opportunities and challenges
Tadas Narutavičius, ISM / Roche IT
12:25 - 12:30
Q&A and discussion
12:30 - 12:45
COFFEE BREAK
12:45 - 15:15
II SESSION
Moderators: Assoc. prof. Birutė Brasiūnienė, Dr. Jurgita Gudaitienė
12:45 - 13:05
Beyond PARP & BRCA: Next generation approaches to HRD
Dr. Jurgita Gudaitienė, Hospital of Lithuanian University of Health Sciences Kaunas Clinics
13:05 - 13:25
Should stage I triple-negative breast cancer receive neoadjuvant chemo-immunotherapy?
Monika Drobnienė, National Cancer Center, Vilnius University Hospital Santaros Klinikos
13:25 - 13:45
ER-low: What we know and don't know in clinical point of view. Contraversies: Pathologist view
Assoc. prof. Lina Poškienė, Hospital of Lithuanian University of Health Sciences Kaunas Clinics
13:45 - 14:05
ER-low: What we know and don't know in clinical point of view. Contraversies: Medical oncologist view
Assoc. prof. Sigita Liutkauskienė, Hospital of Lithuanian University of Health Sciences Kaunas Clinics
14:05 - 14:25
New Look Follow-up
Dr. Agnė Čižauskaitė, Klaipeda University Hospital
14:25 - 14:45
Which older patients truly need chemotherapy?
Danguolė Trumpaitienė, Hospital of Lithuanian University of Health Sciences Kaunas Clinics
14:45 - 15:05
Breast Cancer during pregnancy
Aušra Bankauskaitė-Arnašienė, Klaipeda University Hospital
15:05 - 15:10
Q&A and discussion
15:10 - 15:55
LUNCH BREAK
15:55 - 17:55
III SESSION. SYSTEMIC TREATMENT
Moderators: Monika Drobnienė, Dr. Skaistė Tulytė-Kirzova
15:55 - 16:25
Evolving landscape of pI3K/AKT inhibition in HR+ HER2- locally advanced or metastatic breast cancer
Prof. Sherko Kuemmel, Interdisciplinary Breast unit Clinics, Essen-Mitte, Germany
16:25 - 16:45
Novel anti-estrogen agents to endocrine resistant breast cancer
Rugilė Pikturnienė, Klaipeda University Hospital
16:45 - 17:05
Circulating tumor DNA to monitor endocrine resistance
Augustas Česnavičius, Klaipeda University Hospital
17:05 - 17:25
Targeted therapies for mutation carrier patients with breast cancer
Greta Chlebopaševienė, Hospital of Lithuanian University of Health Sciences Kaunas Clinics
17:25 - 17:45
How much immunotherapy is enough for mBC?
Dr. Skaistė Tulytė-Kirzova, gyd. onkologė chemoterapeutė, Vilnius University Hospital Santaros Klinikos
15:55 - 17:45
III PARALLEL SESSION. LOCAL TREATMENT
Moderators: Dr. Agnė Čižauskaitė, Assoc. prof. Alinta Hegmane
15:55 - 16:15
Acellular Dermal Matrix in Implant-Based Breast Reconstruction: Pros and Cons
Dr. Agnė Čižauskaitė, Klaipeda University Hospital
16:15 – 16:35
Targeted Lymph Node Dissection: We Go Wire-Free!
Eglė Gvazdaitė, Klaipeda University Hospital
16:35 – 16:55
(Im)Possible Resection of Imflammatory Breast Cancer
Monika Atienė, Klaipeda University Hospital
16:55 – 17:15
Do we need to remove all HR+/HER2- breast tumors? Medical oncologist view
Assoc. prof. Alinta Hegmane, Latvian Oncology Centre of Riga East Clinical University Hospital
17:15 – 17:35
Vacuum-Assisted Breast Biopsy. Is it Worth? When is it Worth?
Margarita Šalašidi, Hospital of Lithuanian University of Health Sciences Kaunas Clinics
17:35 - 17:45
Klausimai/atsakymai
18:10 - 18:55
IV sesija. NATIONAL CONSENSUS of Lithuanian Breast Cancer Centres: Guidelines for Diagnosis early and metastatic disease
Moderator: Dr. Agnė Čižauskaitė
18:10 - 18:55
Early Breast Cancer AND Advanced or Metastatic Breast Cancer
Radiological examination:
Breast Imaging (MG, tomo,contrast-enhaced MG, US, MRI)
Distant (CT, MRI or US)
Marking (tumor, lymph nodes, number)
Bone scane and PET CT
Pathology:
Currently used Biomarkers
Not Mandatory Biomarkers
Laboratory Tests:
Renal function
Liver function
Electrolytes
Cancer markers
Other:
Fertility
Distress
Sexual Function
Photographs
Lymphedema Screening
PANEL:
Alvydas Česas, Lithuanian Society for Medical Oncologists
Rita Steponavičienė, Lithuanian Radiation Therapy Association
Agnė Čižauskaitė, Lithuanian Breast Cancer Association
Lina Poškienė, Lithuanian Society of Pathologists
Neringa Čiakienė, Association for Support of Oncological Patients
Jūratė Gruodė, Lithuanian Genetics Association
Saulius Lukoševičius/Diana Mačianskytė, Lithuanian Association of Radiologists
Donatas Vajauskas, Lithuanian Nuclear Medicine Initiative Group
Tomas Biržietis/Saulius Paškauskas, Lithuanian Society of Obstetricians and Gynecologists
Dalius Vitkus, Lithuanian Society of Laboratory medicine
Asta Libikienė, Lithuanian Psychosocial Oncology Association
18:55 - 19:00
Closing of the Conference
